Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates

Area of Science:

• Neuro-oncology
• Cancer Therapeutics
• Molecular Biology

Background:

• Recurrent glioblastoma multiforme (GBM) presents a significant unmet medical need.
• Existing treatments offer limited efficacy and impact on patient survival.
• Developing effective strategies for recurrent GBM is a critical research area.

Purpose of the Study:

• To comprehensively review current and emerging therapeutic strategies for recurrent glioblastoma multiforme.
• To discuss the challenges associated with developing novel treatments for recurrent GBM.
• To provide an overview of chemotherapy, targeted molecular agents, virotherapy/gene therapy, and immunotherapy.

Main Methods:

• Literature review of current and novel therapeutic approaches for recurrent glioblastoma multiforme.
• Analysis of treatment modalities including chemotherapy, targeted agents, virotherapy, gene therapy, and immunotherapy.
• Discussion of challenges in the development of new therapeutic agents for GBM.

Main Results:

• Current treatment options for recurrent glioblastoma multiforme have a limited impact on patient outcomes.
• Novel therapeutic approaches such as targeted molecular agents, virotherapy/gene therapy, and immunotherapy show promise.
• Significant challenges exist in the development and clinical translation of these novel agents.

Conclusions:

• Novel therapeutic strategies are essential to improve outcomes for patients with recurrent glioblastoma multiforme.
• Overcoming challenges in drug development, delivery, and clinical trial design is crucial for advancing recurrent GBM treatment.
• A multi-modal approach combining different therapeutic modalities may offer the best strategy for managing recurrent glioblastoma multiforme.